Biochemical Pharmacology

Chemokines as novel therapeutic targets in inflammatory diseases
pp. 1191-1196(6)
Authors: Ajuebor M.N.; Swain M.G.; Perretti M.

Selective inhibition of STAT3 phosphorylation by sodium salicylate in cardiac fibroblasts
pp. 1197-1207(11)
Authors: Wang Z.; Jiang B.; Brecher P.

In vitro pharmacokinetics and pharmacodynamics of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)
pp. 1209-1218(10)
Authors: Ueda-Kawamitsu H.; Lawson T.A.; Gwilt P.R.

Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance
pp. 1219-1228(10)
Authors: Ma J.; Murphy M.; O'Dwyer P.J.; Berman E.; Reed K.; Gallo J.M.

Chronic ethanol administration decreases the ligand binding properties and the cellular content of the mannose 6-phosphate/insulin-like growth factor II receptor in rat hepatocytes
pp. 1229-1239(11)
Authors: Haorah J.; McVicker D.L.; Byrd J.C.; MacDonald R.G.; Donohue T.M.

Induction of G₂/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes
pp. 1251-1258(8)
Authors: Villamarn S.; Ferrer-Miralles N.; Mansilla S.; Priebe W.; Portugal J.

Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function
pp. 1259-1272(14)
Authors: Detaille D.; Guigas B.; Leverve X.; Wiernsperger N.; Devos P.

Distinct binding properties of the AT₁ receptor antagonist [³H]candesartan to intact cells and membrane preparations
pp. 1273-1279(7)
Authors: Fierens F.L.P.; Vanderheyden P.M.L.; Roggeman C.; Vande Gucht P.; De Backer J.-P.; Vauquelin G.

Troglitazone does not protect rat pancreatic cells against free fatty acid-induced cytotoxicity
pp. 1281-1285(5)
Authors: Cnop M.; Hannaert J.C.; Pipeleers D.G.

Effect of protein-bound uraemic toxins on the thermodynamic characteristics of human albumin
pp. 1287-1296(10)
Authors: Sarnatskaya V.V.; Lindup W.E.; Niwa T.; Ivanov A.I.; Yushko L.A.; Tjia J.; Maslenny V.N.; Korneeva L.N.; Nikolaev V.G.

Dose-dependent cysteine-mediated protection of insulin-producing cells from damage by hydrogen peroxide
pp. 1297-1304(8)
Authors: Rasilainen S.; Nieminen J.M.; Levonen A.-L.; Otonkoski T.; Lapatto R.

Modulation of apoptosis and improved redox metabolism with the use of a new antioxidant formula
pp. 1305-1314(10)
Authors: Mosca L.; Marcellini S.; Perluigi M.; Mastroiacovo P.; Moretti S.; Famularo G.; Peluso I.; Santini G.; De Simone C.

A selective plasmin inhibitor, trans-aminomethylcyclohexanecarbonyl-l-(O-picolyl)tyrosine-octylamide (YO-2), induces thymocyte apoptosis
pp. 1315-1323(9)
Authors: Lee E.; Enomoto R.; Takemura K.; Tsuda Y.; Okada Y.

Protection by ascorbic acid from denaturation and release of cytochrome c, alteration of mitochondrial membrane potential and activation of multiple caspases induced by H₂O₂, in human leukemia cells
pp. 1325-1335(11)
Authors: Gruss-Fischer T.; Fabian I.

Stem cell toxicity of oxazaphosphorine metabolites in comparison to their antileukemic activity
pp. 1337-1341(5)
Authors: Brueggemann S.K.; Schlenke P.; Klich S.; Deeken M.; Peters S.O.; Wagner T.

Modulation of dendritic release of dopamine by metabotropic glutamate receptors in rat substantia nigra
pp. 1343-1352(10)
Authors: Campusano J.M.; Abarca J.; Forray M.I.; Gysling K.; Bustos G.

Developmental regulation of flavin-containing monooxygenase form 1 in the liver and kidney of fetal and neonatal rabbits
pp. 1353-1359(7)
Authors: Larsen-Su S.A.; Krueger S.K.; Yueh M.-F.; Pereira C.B.; Williams D.E.

Modulation of the -adrenergic receptor system of vascular smooth muscle cells in vitro and in vivo by chronically elevated endothelin-1 levels
pp. 1361-1369(9)
Authors: Brehm B.R.; Wolf S.C.; Freudenberg J.; Friedmann F.; Heinle H.; Schulze-Osthoff K.

Inhibition of gluconeogenesis by vanadium and metformin in kidney-cortex tubules isolated from control and diabetic rabbits
pp. 1371-1382(12)
Authors: Kiersztan A.; Modzelewska A.; Jarzyna R.; Jagielska E.; Bryla J.